Clinical Trials Directory

Trials / Completed

CompletedNCT06010121

Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin D3

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
AronPharma Sp. z o. o. · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim of the study was to compare the profiles of 25-hydroxyvitamin D serum concentration in healthy adults after 4 weeks of using vitamin D supplementation either in a liposomal or a traditional formulation.

Detailed description

The study will be randomized, cross-over, participants will be randomly assigned to one of the study groups: A) the group receiving vitamin D3 in traditional formulation B) the group receiving vitamin D3 in liposomal formulation. The day before the start of supplementation (T0), 2 weeks (T1) and 4 weeks (T2) after the start of supplementation, participants will have their blood drawn. Then, after a wash-out period of 2 months, the groups will be switched. Participants will again receive daily supplementation with vitamin D3 for 4 weeks. Blood will be drawn before the start of supplementation (T0), 2 weeks (T1) and 4 weeks (T2) after the start of supplementation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLiposomal Vitamin D2000 IU of cholecalciferol in liposomal formulation
DIETARY_SUPPLEMENTTraditional Vitamin D2000 IU of cholecalciferol in traditional formulation

Timeline

Start date
2023-02-17
Primary completion
2023-06-06
Completion
2023-06-06
First posted
2023-08-24
Last updated
2023-08-25

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06010121. Inclusion in this directory is not an endorsement.